Nateglinide
Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.

Catalog Number | T1674 |
Alternative Name(s) | A4166 , Senaglinide |
Research Area | Metabolism|||Membrane transporter/Ion channel|||DNA Damage/DNA Repair|||Ubiquitination|||Proteases/Proteasome |
Molecular Formula | C19H27NO3 |
CAS# | 105816-04-4 |
Purity | 99.78% |
SMILES | CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O |
Size | 10 mg |
Supplier Page | https://www.targetmol.com/compound/Nateglinide |
Additional Information | https://www.targetmol.com/datasheet/T1674 |